Publikationen 2009 - Klinik und Poliklinik für Psychiatrie und

Transcription

Aktuelle Publikationen von Mitarbeitern oder unter Beteiligung von Mitarbeitern der Klinik und
Poliklinik für Psychiatrie und Psychotherapie im Jahr 2009
Articles, Editorial Material, Letters, News Items, Notes und Reviews
Alexopoulos P, Günther F, Popp J, Jessen F, Peters O, Wolf S, Kneib T, Kurz A, Richter-Schmidinger
T, Lewczuk P, Bleich S, Wiltfang J, Kornhuber J. Plasma homocysteine and cerebrospinal fluid (CSF)
neurodegeneration biomarkers in mild cognitive impairment (MCI) and dementia.
J Am Geriatr Soc. 2009;57(4): 737-9 (Impact(2008)=3.805)
Bach JP, Oertel WH, Dodel R, Jessen F. Treatment of hypersexuality in Parkinson's disease with
carbamazepine--a case report.
Mov Disord. 2009;24(8): 1241-2 (Impact(2008)=3.898)
Backmund M, Schütz C, Meyer K, Edlin BR, Reimer J. The risk of emergency room treatment due to
overdose in injection drug users.
J Addict Dis. 2009;28(1): 68-73 (Impact(2008)=1.182)
Ball HA, Samaan Z, Brewster S, Craddock N, Gill M, Korszun A, Maier W, Middleton L, Mors O, Owen
MJ, Perry J, Preisig M, Rice J, Rietschel M, Jones L, Jones I, Farmer AE, McGuffin P. Depression,
migraine with aura and migraine without aura: their familiality and interrelatedness.
Cephalalgia. 2009;29(8): 848-54 (Impact(2008)=3.686)
Block W, Träber F, von Widdern O, Metten M, Schild H, Maier W, Zobel A, Jessen F. Proton MR
spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates
and predictors of treatment response.
Int J Neuropsychopharmacol. 2009;12(3): 415-22 (Impact(2008)=4.378)
Brockmann H*, Zobel A*, Joe A, Biermann K, Scheef L, Schuhmacher A, von Widdern O, Metten
M, Biersack HJ, Maier W, Boecker H. The value of HMPAO SPECT in predicting treatment response
to citalopram in patients with major depression.
Psychiatry Res. 2009;173(2): 107-12 (Impact(2008)=2.666)
* contributed equally
Cohen MX, Axmacher N, Lenartz D, Elger CE, Sturm V, Schläpfer TE. Good vibrations: crossfrequency coupling in the human nucleus accumbens during reward processing.
J Cogn Neurosci. 2009;21(5): 875-89 (Impact(2008)=4.867)
Cohen MX, Axmacher N, Lenartz D, Elger CE, Sturm V, Schläpfer TE. Neuroelectric signatures of
reward learning and decision-making in the human nucleus accumbens.
Neuropsychopharmacology. 2009;34(7): 1649-58 (Impact(2008)=6.835)
Cohen MX, Axmacher N, Lenartz D, Elger CE, Sturm V, Schläpfer TE. Nuclei accumbens phase
synchrony predicts decision-making reversals following negative feedback.
J Neurosci. 2009;29(23): 7591-8 (Impact(2008)=7.452)
Combarros O, van Duijn CM, Hammond N, Belbin O, Arias-Vásquez A, Cortina-Borja M, Lehmann
MG, Aulchenko YS, Schuur M, Kölsch H, Heun R, Wilcock GK, Brown K, Kehoe PG, Harrison R,
Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Morgan K, Warden DR, Smith AD, Lehmann DJ.
Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk
of Alzheimer's disease.
J Neuroinflammation. 2009;6: 22 (Impact(2008)=3.206)
Dobrusin M, Weitzman D, Levine J, Kremer I, Rietschel M, Maier W, Belmaker RH. The rate of
consanguineous marriages among parents of schizophrenic patients in the Arab Bedouin population in
Southern Israel.
World J Biol Psychiatry. 2009;10(4): 334-6 (Impact(2008)=3.582)
Ehreke L, Luppa M, Luck T, Wiese B, Weyerer S, Eifflaender-Gorfer S, Weeg D, Olbrich J, van den
Bussche H, Bachmann C, Eisele M, Maier W, Jessen F, Wagner M, Fuchs A, Pentzek M,
Angermeyer MC, König HH, Riedel-Heller SG; AgeCoDe group. Is the clock drawing test appropriate
for screening for mild cognitive impairment?--Results of the German study on Ageing, Cognition and
Dementia in Primary Care Patients (AgeCoDe).
Dement Geriatr Cogn Disord. 2009;28(4): 365-72 (Impact(2008)=3.142)
Esslinger C*, Walter H*, Kirsch P*, Erk S, Schnell K, Arnold C, Haddad L, Mier D, Opitz von
Boberfeld C, Raab K, Witt SH, Rietschel M, Cichon S, Meyer-Lindenberg A. Neural mechanisms of a
genome-wide supported psychosis variant.
Science. 2009;324: 605 (Impact(2008)=28.103)
* shared first authorship
Ganda C, Schwab SG, Amir N, Heriani H, Irmansyah I, Kusumawardhani A, Nasrun M, Widyawati I,
Maier W, Wildenauer DB. A family-based association study of DNA sequence variants in GRM7 with
schizophrenia in an Indonesian population.
George MS, Padberg F, Schläpfer TE, O'Reardon JP, Fitzgerald PB, Nahas ZH, Marcolin MA.
Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation
shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessivecomplusive disorder, panic, posttraumatic stress disorder).
Brain Stimulat. 2009;2(1): 14-21
Gerbershagen K, Gerbershagen HJ, Lutz J, Cooper-Mahkorn D, Wappler F, Limmroth V,
Gerbershagen M. Pain prevalence and risk distribution among inpatients in a German teaching
hospital.
Clin J Pain. 2009;25(5): 431-7 (Impact(2008)=2.889)
Goossens L, Kukolja J, Onur OA, Fink GR, Maier W, Griez E, Schruers K, Hurlemann R. Selective
processing of social stimuli in the superficial amygdala.
Hum Brain Mapp. 2009;30(10): 3332-8 (Impact(2008)=5.395)
Gründer G, Aldenhoff J, Bergmann F, Eckermann G, Maier W, Möller HJ, Fritze J. Stellungnahme der
Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Psychotherapie (DGPPN) zu den
"Empfehlungen der Arzneimittelkommission der deutschen Ärzteschaft zur Verordnung von
benzodiazepinhaltigen Hypnotika".
Nervenarzt. 2009;80(2): 219-21 (Impact(2008)=0.814)
Günther U, Muders T, Wrigge H, Popp J, Andorfer U, Putensen C. Deutsche Kurzversion: Confusion
Assessment Method for Intensive Care Unit zur routinemäßigen Kontrolle des Delirs auf der
Intensivstation.
Anästhesiologie und Intensivmedizin. 2009;10: 592-600
Haasen C, Eiroa-Orosa FJ, Verthein U, Soyka M, Dilg C, Schäfer I, Reimer J. Effects of heroinassisted treatment on alcohol consumption: findings of the German randomized controlled trial.
Alcohol. 2009;43(4): 259-64 (Impact(2008)=2.363)
Haenisch B, Linsel K, Brüss M, Gilsbach R, Propping P, Nöthen MM, Rietschel M, Fimmers R, Maier
W, Zobel A, Höfels S, Guttenthaler V, Göthert M, Bönisch H. Association of major depression with
rare functional variants in norepinephrine transporter and serotonin(1A) receptor genes.
Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7): 1013-6 (Impact(2008)=3.932)
Hamshere ML, Schulze TG, Schumacher J, Corvin A, Owen MJ, Jamra RA, Propping P, Maier W,
Orozco y Diaz G, Mayoral F, Rivas F, Jones I, Jones L, Kirov G, Gill M, Holmans PA, Nöthen MM,
Cichon S, Rietschel M, Craddock N. Mood-incongruent psychosis in bipolar disorder: conditional
linkage analysis shows genome-wide suggestive linkage at 1q32.3, 7p13 and 20q13.31.
Bipolar Disord. 2009;11(6): 610-20 (Impact(2008)=3.959)
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V,
Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P,
Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore
PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J,
Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, van den Bussche H,
Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM,
Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De
Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas
P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus
S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA,
O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and
PICALM associated with Alzheimer's disease.
Nat Genet. 2009;41(10): 1088-93. Erratum in: Nat Genet. 2009;41(10): 1156 (Impact(2008)=30.259)
Hohoff C, Neumann A, Domschke K, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P,
Rothermundt M, Arolt V, Deckert J. Association analysis of Rgs7 variants with panic disorder.
J Neural Transm. 2009;116(11): 1523-8 (Impact(2008)=2.514)
Holmans PA, Riley B, Pulver AE, Owen MJ, Wildenauer DB, Gejman PV, Mowry BJ, Laurent C,
Kendler KS, Nestadt G, Williams NM, Schwab SG, Sanders AR, Nertney D, Mallet J, Wormley B,
Lasseter VK, O'Donovan MC, Duan J, Albus M, Alexander M, Godard S, Ribble R, Liang KY, Norton
N, Maier W, Papadimitriou G, Walsh D, Jay M, O'Neill A, Lerer FB, Dikeos D, Crowe RR, Silverman
JM, Levinson DF. Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample
using single nucleotide polymorphisms.
Mol Psychiatry. 2009;14(8): 786-95 (Impact(2008)=12.537)
Hong GS, Heun R, Jessen F, Popp J, Hentschel F, Kelemen P, Schulz A, Maier W, Kölsch H.
Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Neurobiol Aging. 2009;30(5): 691-6 (Impact(2008)=5.959)
Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J,
Souery D, Placentino A, Zobel A, Larsen ER, Czerski PM, Gupta B, Hoda F, Perroud N, Farmer A,
Craig I, Aitchison KJ, McGuffin P. Moderation of antidepressant response by the serotonin transporter
gene.
Br J Psychiatry. 2009;195(1): 30-8 (Impact(2008)=5.077)
Hurlemann R*, Schläpfer TE*, Matusch A, Reich H, Shah NJ, Zilles K, Maier W, Bauer A. Reduced
5-HT(2A) receptor signaling following selective bilateral amygdala damage.
Soc Cogn Affect Neurosci. 2009;4(1): 79-84
Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW,
Wittchen HU, Schütz CG. Reduced memory and attention performance in a population-based sample
of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
J Psychopharmacol. 2009;23(5): 495-509 (Impact(2008)=4.063)
Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J,
Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Bottlender R, Strauss A, Möller
HJ. Prediction of symptom remission in schizophrenia during inpatient treatment.
World J Biol Psychiatry. 2009;10(4 Pt 2): 426-34 (Impact(2008)=3.582)
Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, G Schmidt L, Gaebel W, Klosterkötter J, Heuser I,
Maier W, Lemke MR, Degner D, Buchkremer G, Gastpar M, Möller HJ, Riedel M. Early improvement
as a predictor of remission and response in schizophrenia: results from a naturalistic study.
Eur Psychiatry. 2009;24(8): 501-6 (Impact(2008)=2.433)
Janowitz D, Grabe HJ, Ruhrmann S, Ettelt S, Buhtz F, Hochrein A, Schulze-Rauschenbach S,
Meyer K, Kraft S, Ferber C, Pukrop R, Freyberger HJ, Klosterkötter J, Falkai P, John U, Maier W,
Wagner M. Early onset of obsessive-compulsive disorder and associated comorbidity.
Depress Anxiety. 2009;26(11): 1012-7 (Impact(2008)=2.526)
Jessen F. Bildgebende Verfahren in der Diagnostik der Alzheimer Demenz.
Journal für Neurologie, Neurochirurgie und Psychiatrie. 2009;3: 70-3
Jessen F. Diagnostik von Demenzerkrankungen.
Heilberufe. 2009;61(6): 4
Jessen F. Diagnostische Schärfe des Mini-Mental-Status Tests - Wann ist der Einsatz in der
Hausarztpraxis sinnvoll?
Info Neurologie & Psychiatrie. 2009;6: 20-1
Jessen F. Prävention und Frühbehandlung von Demenzen.
Neuro Aktuell. 2009;6: 32-5
Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Kornhuber J, Wiltfang J, Kucinski T, Jahn
H, Heun R, Maier W, Kölsch H, Träber F. A multicenter (1)H-MRS study of the medial temporal lobe
in AD and MCI.
Neurology. 2009;72(20): 1735-40 (Impact(2008)=7.043)
Jessen F, Maier W, Spottke A, Deuschl G. S3-Leitlinie Demenzen: Eine integrative Leistung zwischen
Neurologie und Psychiatrie/Psychotherapie.
MedReport. 2009;44: 15
Jessen F, Schuhmacher A, von Widdern O, Guttenthaler V, Höfels S, Suliman H, Scheef L, Block
W, Urbach H, Maier W, Zobel A. No association of the val66met polymorphism of the brain-derived
neurotrophic factor with hippocampal volume in major depression.
Psychiatr Genet. 2009;19(2): 99-101 (Impact(2008)=2.696)
Kayser S, Bewernick B, Axmacher N, Schläpfer TE. Magnetic seizure therapy of treatment-resistant
depression in a patient with bipolar disorder.
J ECT. 2009;25(2): 137-40 (Impact(2008)=0.974)
Kilts CD, Wade AG, Andersen HF, Schläpfer TE. Baseline severity of depression predicts
antidepressant drug response relative to escitalopram.
Expert Opin Pharmacother. 2009;10(6): 927-36 (Impact(2008)=2.077)
Kircher TJ, Thienel R, Wagner M, Reske M, Habel U, Kellermann T, Frommann I, Schwab SG,
Wölwer W, von Wilmsdorf S, Braus DF, Schmitt A, Rapp A, Stöcker T, Shah J, Henn FA, Sauer H,
Gaebel W, Maier W, Schneider F. Neuregulin 1 ICE-single nucleotide polymorphism in first episode
schizophrenia correlates with cerebral activation in fronto-temporal areas.
Eur Arch Psychiatry Clin Neurosci. 2009;259(2): 72-9 (Impact(2008)=2.852)
Klafki HW, Lewczuk P, Kamrowski-Kruck H, Maler JM, Müller K, Peters O, Heuser I, Jessen F, Popp
J, Frölich L, Wolf S, Prinz B, Luckhaus C, Schröder J, Pantel J, Gertz HJ, Kölsch H, Müller BW,
Esselmann H, Bibl M, Kornhuber J, Wiltfang J. Measurement of ERK 1/2 in CSF from patients with
neuropsychiatric disorders and evidence for the presence of the activated form.
J Alzheimers Dis. 2009;18(3): 613-22 (Impact(2008)=5.101)
Klingberg S, Wittorf A, Bechdolf A, Herrlich J, Kircher T, König HH, Müller B, Sartory G, Wagner M,
Wiedemann G, Wölwer W, Buchkremer G. Psychotherapieforschung zur Kognitiven
Verhaltenstherapie bei Positiv-Symptomen psychotischer Störungen.
Psychother Psychosom Med Psychol. 2009;59(3-4): 141-8 (Impact(2008)=1.212)
Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Novak N, Beyer M, Mayer G,
Langhans B, Klockgether T, Waisman A, Eberl G, Schultze J, Famulok M, Kolanus W, Glass C, Kurts
C, Knolle PA. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cellintrinsic fashion and suppresses CNS autoimmunity.
J Exp Med. 2009;206(10): 2079-89 (Impact(2008)=15.463)
Klotz L, Schmidt S, Heun R, Klockgether T, Kölsch H. Association of the PPAR gamma gene
polymorphism Pro12Ala with delayed onset of multiple sclerosis.
Neurosci Lett. 2009;449(1): 81-3 (Impact(2008)=2.200)
Kölsch H, Jessen F, Wiltfang J, Lewczuk P, Dichgans M, Teipel S, Kornhuber J, Frölich L, Heuser I,
Peters O, Wiese B, Kaduszkiewicz H, van den Bussche H, Hüll M, Kurz M, Rüther E, Henn FA, Maier
W. Association of SORL1 gene variants with Alzheimer's disease.
Brain Res. 2009;1264: 1-6 (Impact(2008)=2.494)
Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Friedrichs S, Maier W, Heun R.
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism.
J Cell Mol Med. 2009;13(3): 589-98 (Impact(2008)=5.114)
Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R.
CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H*, Wagner M*, Bilkei-Gorzó A, Toliat MR, Pentzek M, Fuchs A, Kaduszkiewicz H, van den
Bussche H, Riedel-Heller SG, Angermeyer MC, Weyerer S, Werle J, Bickel H, Mösch E, Wiese B,
Daerr M, Jessen F, Maier W, Dichgans M. Gene polymorphisms in prodynorphin (PDYN) are
associated with episodic memory in the elderly.
Kornhuber J, Schmidtke K, Frölich L, Perneczky R, Wolf S, Hampel H, Jessen F, Heuser I, Peters O,
Weih M, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Pantel J, Rienhoff O, Seuchter SA,
Rüther E, Henn F, Maier W, Wiltfang J. Early and differential diagnosis of dementia and mild cognitive
impairment. Design and cohort baseline characteristics of the German Dementia Competence
Network.
Dement Geriatr Cogn Disord. 2009;27(5): 404-17 (Impact(2008)=3.142)
Linden M, Maier W, Möller HJ, Sass H. Wissenschaft lebt von der Auseinandersetzung.
Lisanby SH, Pallanti S, Schläpfer TE. FDA considers classification of ECT.
CNS Spectr. 2009;14(12): 668-70 (Impact(2008)=1.974)
Luck T, Riedel-Heller SG, Wiese B, Stein J, Weyerer S, Werle J, Kaduszkiewicz H, Wagner M, Mösch
E, Zimmermann T, Maier W, Bickel H, van den Bussche H, Jessen F, Fuchs A, Pentzek M; für die
AgeCoDe Study Group. CERAD-NP-Testbatterie: Alters-, geschlechts- und bildungsspezifische
Normen ausgewählter Subtests.
Z Gerontol Geriatr. 2009;42(5): 372-84 (Impact(2008)=0.691)
Maier W. [Evidence-based medicine in diagnosis and therapy of depression].
MMW Fortschr Med. 2009;151(13): 86-8
Maier W, Falkai P. Neues zur Diagnostik und Therapie schizophrener Psychosen.
Nervenarzt. 2009;80(1): 5 (Impact(2008)=0.814)
Marziniak M, Kienzler C, Kuhlenbäumer G, Sommer C, Mössner R. Functional gene variants of the
serotonin-synthesizing enzyme tryptophan hydroxylase 2 in migraine.
Mauri MC, Turner M, Volonteri LS, Medori R, Maier W. Dosing patterns in Europe: efficacy and safety
of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg.
Int J Psychiatry Clin Pract. 2009;13(1): 36-47 (Impact(2008)=0.410)
McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE,
Kusenda M, Krastoshevsky O, Krause V, Kumar RA, Grozeva D, Malhotra D, Walsh T, Zackai EH,
Kaplan P, Ganesh J, Krantz ID, Spinner NB, Roccanova P, Bhandari A, Pavon K, Lakshmi B, Leotta
A, Kendall J, Lee YH, Vacic V, Gary S, Iakoucheva LM, Crow TJ, Christian SL, Lieberman JA, Stroup
TS, Lehtimäki T, Puura K, Haldeman-Englert C, Pearl J, Goodell M, Willour VL, Derosse P, Steele J,
Kassem L, Wolff J, Chitkara N, McMahon FJ, Malhotra AK, Potash JB, Schulze TG, Nöthen MM,
Cichon S, Rietschel M, Leibenluft E, Kustanovich V, Lajonchere CM, Sutcliffe JS, Skuse D, Gill M,
Gallagher L, Mendell NR; Wellcome Trust Case Control Consortium, Craddock N, Owen MJ,
O'Donovan MC, Shaikh TH, Susser E, Delisi LE, Sullivan PF, Deutsch CK, Rapoport J, Levy DL, King
MC, Sebat J. Microduplications of 16p11.2 are associated with schizophrenia.
Nat Genet. 2009;41(11): 1223-7 (Impact(2008)=30.259)
Mössner R, Maier W, Rujescu D. Neue Erkenntnisse zur Genetik der Schizophrenie.
Nervenarzt. 2009;80(1): 6, 8, 10-1 (Impact(2008)=0.814)
Mössner R, Schuhmacher A, Kühn KU, Cvetanovska G, Rujescu D, Zill P, Quednow BB, Rietschel
M, Wölwer W, Gaebel W, Wagner M, Maier W. Functional serotonin 1A receptor variant influences
treatment response to atypical antipsychotics in schizophrenia.
Pharmacogenet Genomics. 2009;19(1): 91-4 (Impact(2008)=4.409)
Müller S. Enthemmt durch Tiefe Hirnstimulation.
Ärztliche Praxis Neurologie/Psychiatrie. 2009;23(8): 30-1
Müller S. Magnetic fluid hyperthermia therapy for malignant brain tumours - an ethical discussion.
Nanomedicine: Nanotechnology, Biology and Medicine. 2009;5(4): 387-93
Musshoff F, Lachenmeier K, Lichtermann D, Madea B. Cocaine and opiate concentrations in hair
from subjects in a heroin maintenance program in comparison to a methadone substituted group.
Int J Legal Med. 2009;123(5): 363-9 (Impact(2008)=2.574)
Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE,
Irmansyah, Holmans PA, Escamilla M, Wildenauer DB, Williams NM, Laurent C, Mowry BJ,
Brzustowicz LM, Maziade M, Sklar P, Garver DL, Abecasis GR, Lerer B, Fallin MD, Gurling HM,
Gejman PV, Lindholm E, Moises HW, Byerley W, Wijsman EM, Forabosco P, Tsuang MT, Hwu HG,
Okazaki Y, Kendler KS, Wormley B, Fanous A, Walsh D, O'Neill FA, Peltonen L, Nestadt G, Lasseter
VK, Liang KY, Papadimitriou GM, Dikeos DG, Schwab SG, Owen MJ, O'Donovan MC, Norton N, Hare
E, Raventos H, Nicolini H, Albus M, Maier W, Nimgaonkar VL, Terenius L, Mallet J, Jay M, Godard S,
Nertney D, Alexander M, Crowe RR, Silverman JM, Bassett AS, Roy MA, Mérette C, Pato CN, Pato
MT, Roos JL, Kohn Y, Amann-Zalcenstein D, Kalsi G, McQuillin A, Curtis D, Brynjolfson J,
Sigmundsson T, Petursson H, Sanders AR, Duan J, Jazin E, Myles-Worsley M, Karayiorgou M, Lewis
CM. Meta-analysis of 32 genome-wide linkage studies of schizophrenia.
O’Donovan MC, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L,
Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CCA, Howie B, Leung H-T, Giegling I,
Hartmann AM, Möller H-J, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W,
Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, Iwata N, Ikeda M, Darvasi A, Shifman
S, He L, Duan J, Sanders AR, Levinson DF, Adolfsson R, Ösby U, Terenius L, Jönsson EG, Cichon S,
Nöthen MM, Gill M, Corvin AP, Rujescu D, Gejman PV, Kirov G, Craddock N, Williams NM, Owen MJ,
Molecular Genetics of Schizophrenia Collaboration. Analysis of 10 independent samples provides
evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor
2.
Onur OA, Walter H, Schläpfer TE, Rehme AK, Schmidt C, Keysers C, Maier W, Hurlemann R.
Noradrenergic enhancement of amygdala responses to fear.
Pentzek M, Fuchs A, Wiese B, Cvetanovska-Pllashniku G, Haller F, Maier W, Riedel-Heller SG,
Angermeyer MC, Bickel H, Mösch E, Weyerer S, Werle J, van den Bussche H, Eisele M,
Kaduszkiewicz H; AgeCoDe study group. General practitioners' judgment of their elderly patients'
cognitive status.
J Gen Intern Med. 2009;24(12): 1314-7 (Impact(2008)=2.720)
Pentzek M, Wollny A, Wiese B, Jessen F, Haller F, Maier W, Riedel-Heller SG, Angermeyer MC,
Bickel H, Mösch E, Weyerer S, Werle J, Bachmann C, Zimmermann T, van den Bussche H, Abholz
HH, Fuchs A, AgeCoDe Study Group. Apart from nihilism and stigma: what influences general
practitioners' accuracy in identifying incident dementia?
Am J Geriatr Psychiatry. 2009;17(11): 965-75 (Impact(2008)=4.022)
Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, Marusic A, Maier W, Mors O, Placentino A,
Henigsberg N, Rietschel M, Hauser J, Souery D, Kapelski P, Bonvicini C, Zobel A, Jorgensen L,
Petrovic A, Kalember P, Schulze TG, Gupta B, Gray J, Lewis CM, Farmer AE, McGuffin P, Craig I.
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP
project.
Neuropsychopharmacology. 2009;34(12): 2517-28 (Impact(2008)=6.835)
Perroud N, Uher R, Marusic A, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Souery D,
Placentino A, Szczepankiewicz A, Jorgensen L, Strohmaier J, Zobel A, Giovannini C, Elkin A,
Gunasinghe C, Gray J, Campbell D, Gupta B, Farmer AE, McGuffin P, Aitchison KJ. Suicidal ideation
during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic
Drugs for Depression (GENDEP): a clinical trial.
BMC Med. 2009;7(1): 60 (Impact(2008)=3.276)
Petrovsky N, Schmechtig A, Flomen RH, Kumari V, Collier D, Makoff A, Wagner M, Ettinger U.
CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance.
Petrovsky N, Weiss-Motz F, Schulze-Rauschenbach S, Lemke M, Hornung P, Ruhrmann S,
Klosterkötter J, Maier W, Ettinger U, Wagner M. Antisaccade performance is related to genetic
loading for schizophrenia.
J Psychiatr Res. 2009;43(3): 291-7 (Impact(2008)=4.679)
Piechatzek M, Indlekofer F, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW,
Wittchen HU, Schütz CG. Is moderate substance use associated with altered executive functioning in
a population-based sample of young adults?
Hum Psychopharmacol. 2009;24(8): 650-65 (Impact(2008)=2.08)
Popp J, Bacher M, Kölsch H, Noelker C, Deuster O, Dodel R, Jessen F. Macrophage migration
inhibitory factor in mild cognitive impairment and Alzheimer’s disease.
Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kölsch H, Frommann I, Kornhuber
J, Maier W, Jessen F. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's
disease.
J Alzheimers Dis. 2009;18(4): 819-28 (Impact(2008)=5.101)
Popp J, Schaper K, Kölsch H, Cvetanovska G, Rommel F, Klingmüller D, Dodel R, Wüllner U,
Jessen F. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
Neurobiol Aging. 2009;30(3): 498-500 (Impact(2008)=5.959)
Poustka F, Maier W. Genetik der kognitiven Fähigkeiten in der Lebensspanne.
Preibisch C, Lanfermann H, Wallenhorst T, Walter H, Erk S. Neuroanatomical correlates of visual field
bias: a sensitive system for detecting potential threads?
Brain Res. 2009;1263: 69-77 (Impact(2008)=2.494)
Quednow BB, Schmechtig A, Ettinger U, Petrovsky N, Collier DA, Vollenweider FX, Wagner M,
Kumari V. Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catecholO-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study.
Biol Psychiatry. 2009;66(6): 614-20 (Impact(2008)=8.672)
Qureischie H, Heun R, Popp J, Jessen F, Maier W, Schmitz S, Hentschel F, Kelemen P, Kölsch H.
Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.
Rabins P, Appleby BS, Brandt J, DeLong MR, Dunn LB, Gabriëls L, Greenberg BD, Haber SN,
Holtzheimer PE 3rd, Mari Z, Mayberg HS, McCann E, Mink SP, Rasmussen S, Schläpfer TE, Vawter
DE, Vitek JL, Walkup J, Mathews DJ. Scientific and ethical issues related to deep brain stimulation for
disorders of mood, behavior, and thought.
Arch Gen Psychiatry. 2009;66(9): 931-7 (Impact(2008)=14.273)
Rehme AK, Frommann I, Peters S, Block V, Bludau J, Quednow BB, Maier W, Schütz C, Wagner
M. Startle cue-reactivity differentiates between light and heavy smokers.
Addiction. 2009;104(10): 1757-64 (Impact(2008)=4.244)
Rujescu D, Zill P, Rietschel M, Maier W. Genetik suizidalen Verhaltens.
Nervenheilkunde. 2009;28(4): 211-6 (Impact(2008)=0.373)
Schäfer I*, Hansen H*, Schön G*, Maier W*, Höfels S*, Altiner A*, Fuchs A*, Gerlach FM*, Petersen
JJ*, Gensichen J*, Schulz S*, Riedel-Heller S*, Luppa M*, Weyerer S*, Werle J*, Bickel H*, Barth K*,
König HH*, Rudolph A*, Wiese B, Prokein J*, Bullinger M*, von dem Knesebeck O*, Eisele M*,
Kaduszkiewicz H*, Wegscheider K*, van den Bussche H*. The German MultiCare-study: patterns of
multimorbidity in primary health care - protocol of a prospective cohort study.
BMC Health Serv Res. 2009;9(1): 145 (Impact(2008)=1.680)
* equal contributors
Scheef L, Boecker H, Daamen M, Fehse U, Landsberg MW, Granath DO, Mechling H, Effenberg AO.
Multimodal motion processing in area V5/MT: evidence from an artificial class of audio-visual events.
Brain Res. 2009;1252: 94-104 (Impact(2008)=2.494)
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D,
Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M,
Möller HJ, Riedel M. Defining and predicting functional outcome in schizophrenia and schizophrenia
spectrum disorders.
Schizophr Res. 2009;113(2-3): 210-7 (Impact(2008)=4.174)
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D,
Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S,
Gastpar M, Möller HJ, Riedel M. Attitude towards adherence in patients with schizophrenia at
discharge.
Schläpfer TE, Bewernick BH. Deep brain stimulation for psychiatric disorders--state of the art.
Adv Tech Stand Neurosurg. 2009;34: 37-57
Schläpfer TE, Bewernick BH, Kayser S, Sturm V, Lenartz D, Schnitzler A. Psychiatric Indications for
the Use of Deep Brain Stimulation.
Akt Neurol. 2009;36 Suppl: S24-6 (Impact(2008)=0.295)
Schmitz-Hübsch T*, Schläpfer TE*, Westheide J*, von Falkenhausen M*, Cooper-Mahkorn D*,
Maier W*, Kühn KU*. Clozapine: acquittal of the usual suspect.
World J Biol Psychiatry. 2009;10(4 Pt 3): 981-4 (Impact(2008)=3.582)
Schneider F, Maier W. Psychiatrie in der Lebensspanne.
Schuhmacher A, Mössner R, Quednow BB, Kühn KU, Wagner M, Cvetanovska G, Rujescu D, Zill
P, Möller HJ, Rietschel M, Franke P, Wölwer W, Gaebel W, Maier W. Influence of 5-HT3 receptor
subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics
in schizophrenia.
Pharmacogenet Genomics. 2009;19(11): 843-51 (Impact(2008)=4.409)
Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J, Pearl J, Strohmaier J,
Breuer R, Schwarz M, Propping P, Nöthen MM, Cichon S, Schumacher J; NIMH Genetics Initiative
Bipolar Disorder Consortium, Rietschel M, McMahon FJ. Two variants in Ankyrin 3 (ANK3) are
independent genetic risk factors for bipolar disorder.
Stamelou M, Matusch A, Elmenhorst D, Hurlemann R, Eggert KM, Zilles K, Oertel WH, Höglinger GU,
Bauer A. Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in
progressive supranuclear palsy.
Mov Disord. 2009;24(8): 1170-5 (Impact(2008)=3.898)
Staudinger MR, Erk S, Abler B, Walter H. Cognitive reappraisal modulates expected value and
prediction error encoding in the ventral striatum.
Neuroimage. 2009;47(2): 713-21 (Impact(2008)=5.694)
Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT,
Blackwood D, Cichon S, Coventry WL, Domschke K, Farmer A, Fava M, Gordon SD, He Q, Heath AC,
Heutink P, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hu Y, Kohli M, Lin D, Lucae S, Macintyre DJ,
Maier W, McGhee KA, McGuffin P, Montgomery GW, Muir WJ, Nolen WA, Nöthen MM, Perlis RH,
Pirlo K, Posthuma D, Rietschel M, Rizzu P, Schosser A, Smit AB, Smoller JW, Tzeng JY, van Dyck R,
Verhage M, Zitman FG, Martin NG, Wray NR, Boomsma DI, Penninx BW. Genome-wide association
for major depressive disorder: a possible role for the presynaptic protein piccolo.
Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, Maier W, Mössner R, Gaebel W,
Dahmen N, Fehr C, Scherbaum N, Steffens M, Ludwig KU, Frank J, Wichmann HE, Schreiber S,
Dragano N, Sommer WH, Leonardi-Essmann F, Lourdusamy A, Gebicke-Haerter P, Wienker TF,
Sullivan PF, Nöthen MM, Kiefer F, Spanagel R, Mann K, Rietschel M. Genome-wide association study
of alcohol dependence.
Arch Gen Psychiatry. 2009;66(7): 773-84 (Impact(2008)=14.273)
Treutlein J, Mühleisen TW, Frank J, Mattheisen M, Herms S, Ludwig KU, Treutlein T, Schmael C,
Strohmaier J, Bösshenz KV, Breuer R, Paul T, Witt SH, Schulze TG, Schlösser RG, Nenadic I, Sauer
H, Becker T, Maier W, Cichon S, Nöthen MM, Rietschel M. Dissection of phenotype reveals possible
association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter.
Schizophr Res. 2009;111(1-3): 123-30 (Impact(2008)=4.174)
Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, Kozel D, Hauser J, Souery D,
Placentino A, Strohmaier J, Perroud N, Zobel A, Rajewska-Rager A, Dernovsek MZ, Larsen ER,
Kalember P, Giovannini C, Barreto M, McGuffin P, Aitchison KJ. Adverse reactions to antidepressants.
Br J Psychiatry. 2009;195(3): 202-10 (Impact(2008)=5.077)
Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D,
Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski
PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P,
Craig I. Genetic predictors of response to antidepressants in the GENDEP project.
Pharmacogenomics J. 2009;9(4): 225-33 (Impact(2008)=5.435)
Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O, Henigsberg N, Souery D, Placentino A,
Rietschel M, Zobel A, Dmitrzak-Weglarz M, Petrovic A, Jorgensen L, Kalember P, Giovannini C,
Barreto M, Elkin A, Landau S, Farmer A, Aitchison KJ, McGuffin P. Differential efficacy of escitalopram
and nortriptyline on dimensional measures of depression.
Br J Psychiatry. 2009;194: 252-9 (Impact(2008)=5.077)
Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Henigsberg N, Souery D, Placentino A,
Perroud N, Dernovsek MZ, Strohmaier J, Larsen ER, Zobel A, Leszczynska-Rodziewicz A, Kalember
P, Pedrini L, Linotte S, Gunasinghe C, Aitchison KJ, McGuffin P, Farmer A. Body weight as a predictor
of antidepressant efficacy in the GENDEP project.
J Affect Disord. 2009;118(1-3): 147-54 (Impact(2008)=3.271)
Vasic N, Walter H, Sambataro F, Wolf RC. Aberrant functional connectivity of dorsolateral prefrontal
and cingulate networks in patients with major depression during working memory processing.
Psychol Med. 2009;39(6): 977-87 (Impact(2008)=4.718)
Wade AG, Schläpfer TE, Andersen HF, Kilts CD. Clinical milestones predict symptom remission over
6-month and choice of treatment of patients with major depressive disorder (MDD).
Walter H, Berger M, Schnell K. Neuropsychotherapy: conceptual, empirical and neuroethical issues.
Eur Arch Psychiatry Clin Neurosci. 2009;259 Suppl 2: S173-82 (Impact(2008)=2.852)
Walter H, Ciaramidaro A, Adenzato M, Vasic N, Ardito RB, Erk S, Bara BG. Dysfunction of the social
brain in schizophrenia is modulated by intention type: an fMRI study.
Walter H, Kalckreuth A, Schardt D, Stephan A, Goschke T, Erk S. The temporal dynamics of
voluntary emotion regulation: immediate and delayed neural aftereffects.
PLoS ONE. 2009;4(8): e6726
Walter H, Kammerer H, Frasch K, Spitzer M, Abler B. Altered reward functions in patients on atypical
antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.
Psychopharmacology (Berl). 2009;206(1): 121-32 (Impact(2008)=3.676)
Weyerer S, Schäufele M, Eifflaender-Gorfer S, Köhler L, Maier W, Haller F, CvetanovskaPllashiniku G, Pentzek M, Fuchs A, van den Bussche H, Zimmermann T, Eisele M, Bickel H, Mösch
E, Wiese B, Angermeyer MC, Riedel-Heller SG; for the German AgeCoDe Study group. Further
members of the German AgeCoDe Study group. Heinz-Harald Abholz, Cadja Bachmann, Wolfgang
Blank, Michaela Buchwald, Mirjam Colditz, Moritz Daerr, Frank Jessen, Sven Heinrich, Hanna
Kaduszkiewicz, Teresa Kaufeler, Hans-Helmut König, Tobias Luck, Melanie Luppa, Manfred Mayer,
Julia Olbrich, Heinz-Peter Romberg, Anja Rudolph, Melanie Sauder, Britta Schürmann, Michael
Wagner, Jochen Werle, Anja Wollny. (German Study on Ageing, Cognition, Dementia in Primary Care
Patients). At-risk alcohol drinking in primary care patients aged 75 years and older.
Int J Geriatr Psychiatry. 2009;24(12): 1376-85 (Impact(2008)=2.128)
Wittfoth M, Schardt DM, Fahle M, Herrmann M. How the brain resolves high conflict situations: double
conflict involvement of dorsolateral prefrontal cortex.
Neuroimage. 2009;44(3): 1201-9 (Impact(2008)=5.694)
Wittorf A, Jakobi U, Bechdolf A, Müller B, Sartory G, Wagner M, Wiedemann G, Wölwer W, Herrlich J,
Buchkremer G, Klingberg S. The influence of baseline symptoms and insight on the therapeutic
alliance early in the treatment of schizophrenia.
Wobrock T, Gruber O, Schneider-Axmann T, Wölwer W, Gaebel W, Riesbeck M, Maier W,
Klosterkötter J, Schneider F, Buchkremer G, Möller HJ, Schmitt A, Bender S, Schlösser R, Falkai P.
Internal capsule size associated with outcome in first-episode schizophrenia.
Eur Arch Psychiatry Clin Neurosci. 2009;259(5): 278-83 (Impact(2008)=2.852)
Wolf RC, Vasic N, Sambataro F, Höse A, Frasch K, Schmid M, Walter H. Temporally anticorrelated
brain networks during working memory performance reveal aberrant prefrontal and hippocampal
connectivity in patients with schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8): 1464-73 (Impact(2008)=2.638)
Bücher und Buchbeiträge
Jessen F (2009) Genetik. In: Mahlberg R, Gutzmann H (Hrsg.) Diagnostik und Therapie von
Demenzerkrankungen. Deutscher Ärzte-Verlag, Köln (157-160).
Jessen F (2009) Liquordiagnostik. In: Mahlberg R, Gutzmann H (Hrsg.) Diagnostik und Therapie von
Demenzerkrankungen. Deutscher Ärzte-Verlag, Köln (153-156).
Maier W, Schulz JB, Weggen S, Wolf S (2009) Alzheimer & Demenzen verstehen: Diagnose,
Behandlung, Alltag, Betreuung. Trias, Stuttgart.
Müller S (2009) BIID - Under which circumstances would be amputations of healthy limbs ethically
justified? In: Stirn A, Oddo S, Thiel A (Eds.) Body Integrity Identity Disorder: psychological,
neurobiological, ethical and legal aspects. Pabst, Lengerich (109-123).
Müller S (2009) Dilemmata bei der Behandlung von Hirntumoren am Beispiel von
Akustikusneurinomen. In: Müller O, Clausen J, Maio G (Hrsg.) Das technisierte Gehirn. Ändern die
aktuellen Neurotechnologien das menschliche Selbstverständnis? Mentis Verlag, Paderborn (187217).
Müller S (2009) Ist Cognitive Enhancement zur Steigerung der Intelligenz ethisch geboten?
Diskussion utilitaristischer und idealistischer Argumente. In: Schöne-Seifert B, Talbot D, Opolka U,
Ach J (Hrsg.) Neuro-Enhancement. Ethik vor neuen Herausforderungen. Mentis Verlag, Paderborn
(107-139).
Müller S, Groß D (2009) Akzeptanz von Leistungsbegrenzungen im Gesundheitswesen: Strategien,
Kriterien und Finanzierungsmodelle unter Berücksichtigung ethischer Aspekte. In: Böcken J, Braun B,
Amhof R (Hrsg.) Gesundheitsmonitor 2009: Gesundheitsversorgung und Gestaltungsoptionen aus der
Perspektive der Bevölkerung. Bertelsmann, Gütersloh (258-279).
Müller S, Zaracko A, Groß D, Schmitz D (2009) Chancen und Risiken der Neurowissenschaften.
Lehmanns, Berlin.
Schläpfer TE, Bewernick BH (2009) Deep brain stimulation: method, indications, locations and
efficacy. In: Swartz C (ed.) Electroconvulsive therapy and neuromodulation. Cambridge University
Press, Cambridge, MA.
Schleim S, Spranger T, Walter H (Hrsg.) (2009) Von der Neuroethik zum Neurorecht? Der Beginn
einer neuen Debatte. Vandenhoeck & Ruprecht, Göttingen.
Schleim S, Spranger T, Walter H (2009) Von der Neuroethik zum Neurorecht? In: Schleim S,
Spranger T, Walter H (Hrsg.) Von der Neuroethik zum Neurorecht? Der Beginn einer neuen Debatte.
Vandenhoeck & Ruprecht, Göttingen (7-21).
Walter H (2009) Hirnforschung. In: Bohlken E, Thies C (Hrsg.) Handbuch Anthropologie. Der Mensch
zwischen Natur, Kultur und Technik. Metzler, Stuttgart (137-146).
Walter H (2009) Was können wir messen? In: Schleim S, Spranger T, Walter H (Hrsg.) Von der
Neuroethik zum Neurorecht? Der Beginn einer neuen Debatte. Vandenhoeck & Ruprecht, Göttingen
(67-103).
Walter H, Erk S (2009) Seh' ich da was, was Du nicht siehst? Methoden, Möglichkeiten und Mängel
des Neuroimaging. In: Spitzer M, Bertram W (Hrsg.) Hirnforschung für Neu(ro)gierige.
Braintertainment 2.0. Schattauer, Stuttgart (185-206).

Publikationen 2009 - Klinik und Poliklinik für Psychiatrie und

Transcription

Documents pareils

Anfahrtmöglichkeiten

Publikationen 2007 - Klinik und Poliklinik für Psychiatrie und

Salvatorkolleg verliert zwei anerkannte Pädagogen

Lebenslauf von Dr. GEORG E. KODEK

Ausschreibung Wintertime-Party 31.Okt.2004

Flugblatt zu ATU - IG Metall Pforzheim

Crossline-History vom 26.01.1997

dem Programm-Flyer

DIE KFW STIFTUNG